ARK Investment Management Portfolio holdings
ARK Investment Management LLC, founded in 2014 by Cathie Wood and headquartered in St. Petersburg, Florida, is an investment firm managing over $15 billion in assets as of late 2024, renowned for its focus on disruptive innovation across thematic equity ETFs. With a mission to invest in technologies shaping the future, ARK targets five key areas—artificial intelligence, genomics, autonomous technology, energy storage, and blockchain—offering funds like the ARK Innovation ETF (ARKK) to retail and institutional investors seeking high-growth opportunities. Wood, a former AllianceBernstein economist, leads a team of about 50, emphasizing active management, deep research, and a long-term horizon, often holding volatile, speculative stocks like Tesla and Coinbase, which fueled massive gains in 2020 but faced challenges in 2022’s bear market. Known for its transparent, educational approach—including daily portfolio disclosures and bold predictions like Bitcoin reaching $1 million—ARK has carved a niche as a forward-thinking, risk-embracing player in the investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
10x Genomics
TXG
|
+$79.3M |
| 2 |
Roblox
RBLX
|
+$54.1M |
| 3 |
ARK 21Shares Bitcoin ETF
ARKB
|
+$33.2M |
| 4 |
Recursion Pharmaceuticals
RXRX
|
+$31M |
| 5 |
Shopify
SHOP
|
+$24.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$234M |
| 2 |
Coinbase
COIN
|
+$198M |
| 3 |
EXAS
Exact Sciences
EXAS
|
+$161M |
| 4 |
Robinhood
HOOD
|
+$138M |
| 5 |
Ginkgo Bioworks
DNA
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.86% |
| 2 | Healthcare | 24.46% |
| 3 | Communication Services | 18.33% |
| 4 | Consumer Discretionary | 12.38% |
| 5 | Financials | 12.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Moderna
MRNA
$23.6B
| $125M | 1.11% |
1,054,094
-163,289
| -13% | -$20.7M |
|
27
SoFi Technologies
SOFI
$23.7B
| $96.1M | 0.85% |
14,535,772
-1,687,427
| -10% | -$11.9M |
|
28
Kratos Defense & Security Solutions
KTOS
$11.4B
| $93.3M | 0.83% |
4,660,808
-846,027
| -15% | -$16.5M |
|
29
Archer Aviation
ACHR
$4.26B
| $89.6M | 0.8% |
25,457,388
-2,801,465
| -10% | -$10.4M |
|
30
CareDx
CDNA
$2.42B
| $88.6M | 0.79% |
5,702,351
-161,695
| -3% | -$1.95M |
|
31
Teladoc Health
TDOC
$1.3B
| $73.2M | 0.65% |
7,481,255
-8,553,415
| -53% | -$104M |
|
32
Iridium Communications
IRDM
$5.29B
| $67.1M | 0.6% |
2,520,547
-52,633
| -2% | -$1.48M |
|
33
Ionis Pharmaceuticals
IONS
$9.4B
| $64.9M | 0.58% |
1,361,025
-38,827
| -3% | -$1.59M |
|
34
Trimble
TRMB
$13.9B
| $64.1M | 0.57% |
1,147,045
-168,786
| -13% | -$9.74M |
|
35
AeroVironment
AVAV
$9.45B
| $59M | 0.52% |
323,764
-128,436
| -28% | -$23.1M |
|
36
Toast
TOST
$19.9B
| $57.8M | 0.51% |
2,244,344
-380,020
| -14% | -$9.19M |
|
37
NVIDIA
NVDA
$5.42T
| $51.6M | 0.46% |
417,687
-250,733
| -38% | -$25.4M |
|
38
Nurix Therapeutics
NRIX
$2.65B
| $48.5M | 0.43% |
2,323,332
-312,006
| -12% | -$4.86M |
|
39
Arcturus Therapeutics
ARCT
$211M
| $47.8M | 0.42% |
1,964,964
+275,315
| +16% | +$8.35M |
|
40
Schrodinger
SDGR
$1.36B
| $47.3M | 0.42% |
2,447,629
-70,356
| -3% | -$1.62M |
|
41
Pacific Biosciences
PACB
$368M
| $45.5M | 0.4% |
33,212,454
-77,683
| -0.2% | -$157K |
|
42
Natera
NTRA
$46.4B
| $45M | 0.4% |
415,342
+92,958
| +29% | +$9.44M |
|
43
Spotify
SPOT
$100B
| $44.6M | 0.4% |
142,109
-17,884
| -11% | -$5.38M |
|
44
TSMC
TSM
$2.18T
| $44.6M | 0.4% |
256,429
+11,377
| +5% | +$1.73M |
|
45
Mercado Libre
MELI
$92.3B
| $42.8M | 0.38% |
26,037
-12,260
| -32% | -$19.4M |
|
46
Adaptive Biotechnologies
ADPT
$3.97B
| $41.3M | 0.37% |
11,412,000
+850,704
| +8% | +$2.7M |
|
47
CrowdStrike
CRWD
$218B
| $38.5M | 0.34% |
401,732
-58,208
| -13% | -$4.84M |
|
48
Advanced Micro Devices
AMD
$789B
| $38.4M | 0.34% |
236,798
+46,966
| +25% | +$7.56M |
|
49
Vertex Pharmaceuticals
VRTX
$126B
| $35.4M | 0.31% |
75,464
-14,640
| -16% | -$6.35M |
|
50
Cerus
CERS
$474M
| $35M | 0.31% |
19,900,184
-1,645,012
| -8% | -$2.94M |
|
Similar funds
ARK Investment Management's Q2 2024 Portfolio in Review
As of Q2 2024, ARK Investment Management held 238 positions worth $11.3B, down 22% from $14.4B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
ARK Investment Management withdrew a net $1.68B in Q2 2024, closing 48 positions and reducing 128 holdings. Its most notable exit was StoneCo, an estimated $11.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 29% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, ARK Investment Management opened a new position in Tempus AI worth $18.3M.
- ARK Investment Management's largest Q2 2024 buy was Tempus AI: 522,698 shares worth $18.3M.
- ARK Investment Management added most to 10x Genomics in Q2 2024, an estimated $79.3M increase.
- ARK Investment Management's biggest Q2 2024 reduction was Zoom, cutting an estimated $234M.
- ARK Investment Management fully exited StoneCo in Q2 2024, selling an estimated $11.4M.
- ARK Investment Management's ten largest holdings make up 49% of its $11.3B portfolio in Q2 2024.
- ARK Investment Management opened 9 new positions and closed 48 in Q2 2024.
- ARK Investment Management's portfolio value fell 22% quarter-over-quarter to $11.3B.
Based on ARK Investment Management's 13F filing for Q2 2024, filed 26 Jul 2024.